Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial

AIM: To evaluate the efficacy and safety of dulaglutide 3.0 and 4.5 mg versus 1.5 mg when used as an add‐on to metformin in subgroups defined by age (<65 and ≥65 years). MATERIALS AND METHODS: Of 1842 patients included in this post hoc analysis, 438 were aged 65 years or older and 1404 were young...

Descripción completa

Detalles Bibliográficos
Autores principales: Frias, Juan P., Bonora, Enzo, Nevárez Ruiz, Luis, Hsia, Stanley H., Jung, Heike, Raha, Sohini, Cox, David A., Bethel, M. Angelyn, Konig, Manige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518960/
https://www.ncbi.nlm.nih.gov/pubmed/34159708
http://dx.doi.org/10.1111/dom.14469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518960/
https://www.ncbi.nlm.nih.gov/pubmed/34159708
http://dx.doi.org/10.1111/dom.14469

Ejemplares similares